ranatensin [6692]



ranatensin


SMILES CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1cnc[nH]1)NC(=O)CNC(=O)C(NC(=O)C(C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(NC(=O)C1CCC(=O)N1)C(C)C)C(C)C)C(N)=O
InChIKey AUOCWSNQHWTPIJ-UHFFFAOYSA-N
Sequence XVPQWAVGHFM
HELM PEPTIDE1{[*C(=O)C1CCC(=O)N1 |$_R2;;;;;;;;$|].(V,[dV]).(P,[dP]).(Q,[dQ]).(W,[dW]).(A,[dA]).(V,[dV]).G.(H,[dH]).(F,[dF]).(M,[dM]).[am]}$$$$V2.0

Chemical Properties

Hydrogen bond acceptors 15
Hydrogen bond donors 14
Rotatable bonds 34
Log P -1.981
Molecular weight (Da) 1280.6
Stereochemistry info unspecified

Database connections

Model (AF2) BB1 BB2

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

ranatensin


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) BB1 BB2

Compound is not listed as a drug.